Muscle stem cells, which are crucial for building new muscle, don’t work as well as we get older, but giving them an ...

In January 2021, at the height of the pandemic, Sharon Charlebois spent three weeks at the Civic hospital battling a ...

Key market opportunities for mesenchymal stem cells include advancements in regenerative medicine, growing investments in R&D ...

Data demonstrate distinct functional signatures across MSC-derived extracellular vesicles supporting targeted regenerative and aesthetic ...

On track for August 2026 top-line results from Phase 2b clinical trial (ELPIS II) evaluating laromestrocel as a potential adjunct treatment for ...

R3 Stem Cell, a top regenerative medicine company, announced the publication of a systematic review by its Research ...

FDA Regulatory Feedback (HLHS) -- The FDA stated that right ventricle ejection fraction is “not an appropriate endpoint to ...

Pilot data suggest IV mesenchymal stromal cell therapy may improve signs of canine osteoarthritis with no serious safety signals. Gallant reported new pilot data for an intravenous mesenchymal stromal ...

Japan's regenerative medicine market offers opportunities driven by an aging population, progressive regulations, and demand for novel therapies targeting chronic and cosmetic conditions. Innovations ...

A 45-year-old woman with a 2-year vaginal foreign body sensation and constipation has a large posterior vaginal wall mass; a biopsy suggests leiomyoma, but excision reveals angiolipoleiomyoma.

Moderated discussion with Chief Scientific Officer Dr. Robert Pierce on ovarian cancer and evolving treatment landscape ...